Announcements Trials
Browse Landscape

Phase

Phase 1/2 5Phase 1 2Phase 3 1Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

Metastatic Solid Tumors 1Leukemia, Myeloid, Acute 1

Interventions

pembrolizumab 304Paclitaxel 206Carboplatin 200Gemcitabine 173Cisplatin 139Docetaxel 138Cyclophosphamide 136Nivolumab 129Bevacizumab 118Injections 111fludarabine 96atezolizumab 91Pemetrexed 90Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 71Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Lenalidomide 55Ipilimumab 55Midazolam 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Infusions, Intravenous × Clear all
NCT07108114 2026-02-23

SLV-324 Treatment of Metastatic Solid Tumors

Solve Therapeutics

Phase 1 Recruiting
70 enrolled
Other solid neoplasm

Metastatic Solid Tumors

NCT05001451 2022-07-20

Study of GDX012 in Patients With MRD Positive AML

GammaDelta Therapeutics Limited

Phase 1 Terminated
3 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡